UPDATE 1-Gilead first-quarter profit doubles on strong hepatitis C drug sales
April 30, 2015 at 16:50 PM EDT
LOS ANGELES, April 30 (Reuters) - Gilead Sciences Inc said on Thursday its quarterly net profit nearly doubled, driven by sales of its novel hepatitis C drugs, as it topped Wall Street estimates.
